Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic.

Abstract

Journal of the European Academy of Dermatology and VenereologyVolume 37, Issue 1 p. e13-e16 COVID-19 SPECIAL FORUM - LETTER TO THE EDITOR Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic Maria Jose Monroy-Iglesias, Corresponding Author Maria Jose Monroy-Iglesias [email protected] orcid.org/0000-0003-2417-3275 King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK Correspondence Maria Jose Monroy-Iglesias, Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. Email: [email protected]Search for more papers by this authorHajer Hadi, Hajer Hadi King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UKSearch for more papers by this authorBeth Russell, Beth Russell King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UKSearch for more papers by this authorCharlotte Moss, Charlotte Moss King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UKSearch for more papers by this authorLucy Flanders, Lucy Flanders Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UKSearch for more papers by this authorSaoirse Dolly, Saoirse Dolly Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UKSearch for more papers by this authorSophie Papa, Sophie Papa Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UKSearch for more papers by this authorMieke Van Hemelrijck, Mieke Van Hemelrijck King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UKSearch for more papers by this author Maria Jose Monroy-Iglesias, Corresponding Author Maria Jose Monroy-Iglesias [email protected] orcid.org/0000-0003-2417-3275 King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK Correspondence Maria Jose Monroy-Iglesias, Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. Email: [email protected]Search for more papers by this authorHajer Hadi, Hajer Hadi King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UKSearch for more papers by this authorBeth Russell, Beth Russell King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UKSearch for more papers by this authorCharlotte Moss, Charlotte Moss King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UKSearch for more papers by this authorLucy Flanders, Lucy Flanders Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UKSearch for more papers by this authorSaoirse Dolly, Saoirse Dolly Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UKSearch for more papers by this authorSophie Papa, Sophie Papa Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UKSearch for more papers by this authorMieke Van Hemelrijck, Mieke Van Hemelrijck King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UKSearch for more papers by this author First published: 16 August 2022 https://doi.org/10.1111/jdv.18514 Maria Jose Monroy-Iglesias and Hajer Hadi contributed equally to this work as co-first authors. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Volume37, Issue1January 2023Pages e13-e16 This article also appears in:JEADV COVID-19 articles RelatedInformation